When Cytiva recently surveyed the biopharma industry to gain insights into sustainability progress, there was good news and bad news. Companies are succeeding in managing Scope 1 and 2 carbon emissions (Scope 1 covers direct emissions from owned or controlled sources, while Scope 2 covers indirect emissions resulting from the purchase of electricity, steam, heat or cooling)—but when it comes to Scope 3, struggles persist.
Read more...
About the Author
EcoVadis is a purpose-driven company whose mission is to provide the world's most trusted business sustainability ratings. Businesses of all sizes rely on EcoVadis’ expert intelligence and evidence-based ratings to manage risk and compliance, drive decarbonization, and improve the sustainability performance of their business and value chain. Its AI-powered risk mapping, actionable scorecards, benchmarks, carbon action tools, and insights guide a resilience and improvement journey for environmental, social and ethical practices across 200 industry categories and 175 countries.
Follow on Linkedin
Visit Website
More Content by EcoVadis EN
